Evening Primrose Oil 500 mg
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine E | 14.9 UI | Not calculated |
Non-medicinal ingredients
Gélatine, Glycérine, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 3 Chacun ; maximum: 6 Chacun | Not specified |
Uses authorised in Canada
Source of essential fatty acids for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are taking blood thinners and/or anti-psychotics. Consult a health care provider if symptoms persist.
- Contre-indications
Do not use if you are taking black cohosh, chasteberry and/or phenothiazines. Do not use if you have any seizure disorder, mania and/or schizophrenia. Do not use if you are pregnant or breast feeding.
Product record
- Other names
- Evening Primrose Oil
- Licence holder
- RX BALANCE TECHNOLOGY INC.
- NPN or DIN-HM
- 02208865
- Status
- Active licence
- Licence date
- 4 July 2005
- Revision date
- Not provided
- Form
- Gélule
- Route of administration
- Orale
- Application type
- DIN de transition
Source
Official Health Canada record, licence 02208865
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.